Smartphone Check-Ins could save transplanted kidneys
NCT ID NCT05897047
First seen May 01, 2026 · Last updated Jun 18, 2026 · Updated 10 times
Summary
This study tests whether extra telemedicine support (using a smartphone or tablet) can help kidney transplant recipients better manage their health and keep their new kidney working longer. About 384 people who received a kidney transplant in the last year will be split into two groups: one gets standard follow-up care, the other gets additional remote monitoring and check-ins. The goal is to see if telemedicine improves medication adherence, reduces hospital visits, and prevents kidney rejection or failure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Charité Universitätsmedizin Berlin
Berlin, Bavaria, 10117, Germany
-
University Hospital Essen
Essen, Germany
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.